Drug Type Monoclonal antibody |
Synonyms BCG005 |
Target |
Action inhibitors |
Mechanism CCR8 inhibitor(C-C motif chemokine receptor 8 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Regulatory T-lymphocytes inhibitors(Regulatory T-lymphocytes inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | China | - | |
Solid tumor | Discovery | China | - |